10Y UST4.95%+0.81%30Y MTG7.24%-1.09%SOFR3.94%-0.76%VNQ$98.03+3.18%XLRE$45.12+3.32%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire · Capital

Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic

Via PR Newswire · November 5, 2026
Compiled by Real Estate Trail Editorial · November 5, 2026

Why this matters

Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

  • Disclosed capital deal value tracked in November 2026: $2.9B across 9 reported transactions.

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
Anaheim spun out of Alesta Therapeutics prior to its recent acquisition by BioMarin Financing provided by Droia Ventures, Frazier Life Sciences, RTW, Novartis Venture Fund, RV Invest and Thuja Capital Runway into 2028…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

Related coverage — Capital

PR Newswire · Capital

Lumo Homes plc's Interim Report 1 January-30 September 2026

Lumo Homes plc Stock Exchange Release, 05 November 2026 at 8.00 a.m. EET Strong growth continued and the occupancy rate improved in the third quarter HELSINKI, Nov. 5, 2026 /PRNewswire/ -- This is a summary of the 202…

7h ago